Overview
- Editors:
-
-
M.A. Hayat
-
, Kean University, Room 213, Library building, Union, USA
- Treatment of cancer patients
- Methods for tissue engineering
- Role of growth promoting factors in cancer
- Treatment of injuries using cell therapy
- Extensively illustrated with color figures
Access this book
Other ways to access
Table of contents (37 chapters)
-
Mesenchymal Stem Cells
-
- Hai-Yan Huang, Qi-Qun Tang
Pages 205-211
-
- Stéphanie Courtois-Cox, Caroline Moyret-Lalle
Pages 213-229
-
- Sara Strecker, Yaling Liu, Liping Wang, David Rowe, Peter Maye
Pages 231-245
-
- Livia Elena Sima, Stefana Maria Petrescu
Pages 247-259
-
- Sharmili Vidyadaran, Rajesh Ramasamy, Heng Fong Seow
Pages 261-272
-
- Ji-Won Jung, Seunghee Lee, Kyung-Sun Kang
Pages 273-280
-
- Ossama Abbas, Meera Mahalingam
Pages 281-286
-
Hematopoietic Stem Cells
-
Front Matter
Pages 287-287
-
- Donne Bennett D. Caces, Koen Van Besien, Andrew S. Artz, Lucy A. Godley
Pages 289-298
-
- Henning Schade, Luciano J. Costa
Pages 299-306
-
- Gaetano Caramori, Paolo Casolari, Elvira Garofano, Ilja Baart, Marco Contoli, Federico Mazzoni et al.
Pages 307-317
-
- Ana-Violeta Fonseca, Doreen Reichert, Denis Corbeil
Pages 319-331
-
- Francesca Pedini, Mary Anna Venneri, Ann Zeuner
Pages 333-344
-
- Shuxian Jiang, Fu Yigong, Shalom Avraham, Alexandros Makriyannis, Hava Karsenty Avraham
Pages 345-352
-
-
Other Types of Stem Cells
-
Front Matter
Pages 365-365
-
- Hendrik Ungefroren, Ayman Hyder, Hebke Hinz, Norbert Reiling, Evelin Grage-Griebenow, Maren Schulze et al.
Pages 367-375
-
- Thorold W. Theunissen, José C. R. Silva
Pages 377-384
-
- Marco Velasco-Velázquez, Kongming Wu, Emanuele Loro, Richard Pestell
Pages 385-395
-
Parkinson’s Disease
-
Front Matter
Pages 397-397
About this book
The difference among pluripotent stem cells, multipotent stem cells, and unipotent stem cells is pointed out. Vast therapeutic applications of the following specific stem cells in disease and tissue injury are discussed: human embryonic stem cells, human mesenchymal stem cells, germ cell-derived pluripotent stem cells, induced pluripotent stem cells, human umbilical cord blood-derived stem cells, breast tumor stem cells,and hematopoietic stem cells. Because of the potential of human embryonic stem cells to produce unlimited quantities of any human cell type, considerable focus is placed on their therapeutic potential. Because of their pluripotency, these cells have been used in various applications such as tissue engineering, regenerative medicine, pharmacological and toxicological studies, and fundamental studies of cell differentiation. The formation of embryoid bodies, which are three-dimensional aggregates of embryonic stem cells, is explained as this is the first step in cell differentiation. Such embryoid body culture has been widely used as a trigger for the in vitro differentiation of embryonic stem cells. The basic capacity of self-renewal of human embryogenic stem cells is explained. The role of TGF-beta in the propagation of human embryonic stem cells is discussed. The differentiation of human embryonic stem cells into neurons, hepatocytes, cardiomyocytes, and retinal cells is fully explained. Donor policies for hematopoietic stem cells are also explained.
Editors and Affiliations
-
, Kean University, Room 213, Library building, Union, USA
M.A. Hayat